The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Am Dent Assoc, Vol 129, No 9, 1281-1286.
© 1998 American Dental Association
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MOORE, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MOORE, P. A.
Related Collections
Right arrow Pharmacology

CLINICAL PRACTICE

JADA Continuing Education

SELECTING DRUGS FOR THE PREGNANT DENTAL PATIENT



PAUL A. MOORE, D.M.D., PH.D.

When treating pregnant patients, dental practitioners should avoid prescribing some drugs routinely used for local anesthesia, sedation, analgesia or infection. Dental practitioners need to determine that the potential benefits of the drug required for the mother’s dental care outweigh the risks to her fetus. This article briefly reviews the relative risks of therapeutic agents commonly used in dental care to help practitioners select the safest drugs for use by pregnant patients.




This article has been cited by other articles:


Home page
 Journal of the American Dental AssociationHome page
P. A. MOORE and E. V. HERSH
Celecoxib and rofecoxib: The role of COX-2 inhibitors in dental practice
J Am Dent Assoc, April 1, 2001; 132(4): 451 - 456.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-1998 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.